.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
Colorcon
QuintilesIMS
Queensland Health
Argus Health
Healthtrust
Fish and Richardson
Novartis
Johnson and Johnson

Generated: June 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: daclatasvir dihydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0011-0128 TABLET in 1 BOTTLE (0003-0011-01)
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0213-0128 TABLET in 1 BOTTLE (0003-0213-01)
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0215-0128 TABLET in 1 BOTTLE (0003-0215-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Cantor Fitzgerald
Accenture
UBS
Colorcon
Healthtrust
Mallinckrodt
Citi
Express Scripts

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot